Urologists wish to offer the treatment option best suited to each of their patients. For patients with low-risk prostate cancer, urologists could, up to now, offer radical treatment (destruction or removal of the prostate) or active surveillance (follow-up without treatment). Today, a third option is possible with focal therapies (targeted treatment for patients with low-risk prostate cancer).
Professor Jonathan Coleman, urologic surgeon at MKSCC, New-York, USA
Jonathan Coleman, who specialises in treating prostate and kidney cancers, talks about how minimally invasive surgical techniques reduce recovery time and pain, as well as improve quality of life for patients.